Search Results 561-570 of 19235 for alzheimers
Efficacy and Safety Trial of MK-8931 in Participants With Prodromal Alzheimer's Disease (MK-8931-019) · Overview · Participation eligibility · More information ...
Ertekin-Taner's Genetics of Alzheimer's Disease and Endophenotypes Laboratory receives funding from these sources. Grants. Investigator & Role, Grant Title ...
A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease · Overview · Participation eligibility.
Ever since its inception, the director of the Alzheimer's Disease Research Center at. Mayo Clinic, Dr. Ronald Petersen, has served as chair of the advisory ...
Mayo Clinic's Neurobiology of Alzheimer's Disease and Related Dementias Lab led by Na Zhao, M.D., Ph.D., participates in several education programs for ...
... Alzheimer's disease. Memantine and donepezil will not cure Alzheimer's disease, however, it may improve thinking ability, behavior, or functional ability.
Prashanthi Vemuri and colleagues published a study in the journal Neurology that shows keeping your mind active may help ward off symptoms of Alzheimer's.
Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD) · More about research at Mayo Clinic · Mayo ...
Mild cognitive impairment · Alzheimer's disease · Lewy body dementia · Frontotemporal dementia · Primary progressive aphasia · Corticobasal degeneration · Progressive ...
Mayo Clinic's Neurobiology of Alzheimer's Disease and Related Dementias Lab led by Na Zhao, M.D., Ph.D., is studying the role of APOE&APOE receptors in the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.